Tissue engineering is a growing field where
new materials are being developed for implantation into the body. One important area involves
bone graft materials to replace areas of bone lost to trauma or
disease. Traditionally, graft material may be harvested from the bone of the individual receiving the graft material. However, this requires an additional
surgery and additional
recovery. Bone also may be taken from others, or even cadavers, but this introduces
biocompatibility problems as well as the risk of
disease transfer. Ideally, a
biocompatible material is sought that will act as a filler with appropriate
mechanical strength, encourage
bone healing, and degrade to allow new
bone ingrowth without the risk of
disease transfer. The present invention is a new composite bone graft material made from biocompatible poly(D,L-lactic-co-
glycolic acid) (
PLGA) and nano-sized hydroxyapatite particles exposed on its surface using a
gas foaming particle leaching (GF / PL) method. A further embodiment of this invention involves
coating this
PLGA / hydroxyapatite
biomaterial with an adherent, fast, uniform
coating of a mineral such as
apatite. The
PLGA polymer portion of the composite provides sufficient
mechanical strength to replace bone and is degradable over time to allow new
bone tissue ingrowth. The incorporated hydroxyapatite particles increase the
composite material's osteogenic properties by providing sites for tissue attachment and propagation. Finally, a uniform
coating of mineral
apatite on the surface of this novel
biomaterial composite further enhances its osteogenic qualities.